Related Experiment Videos
APS-I/APECED: the clinical disease and therapy
1Hospital for Children and Adolescents, University of Helsinki, PO Box 281, Fin-00029 HYKS, Helsinki, Finland. jaakko.perheentupa@saunalahti.fi
Abstract:
The clinical picture and course of APS-I or APD-I/APECED is widely variable: the list of possible disease components includes some 30 disorders. The initial manifestation may not include any of the known characteristic components, namely, mucocutaneous candidiasis, hypoparathyroidism, or adrenocortical insufficiency. Although mutation detection is available, it does not help to exclude this disease. Diagnostic strategy needs to be based on knowledge of the clinical picture, including the features of ectodermal dystrophy.
Insights
Autoimmune polyendocrine syndrome type 1 (APS-I) presents with diverse symptoms, often lacking typical signs like candidiasis or adrenal insufficiency. Early diagnosis requires recognizing varied clinical features beyond classic components.
Area of Science:
- Endocrinology
- Immunology
- Genetics
Background:
- Autoimmune polyendocrine syndrome type 1 (APS-I), also known as APD-I/APECED, exhibits significant clinical heterogeneity.
- The disease can manifest with up to 30 different components, making diagnosis challenging.
- Classic symptoms such as mucocutaneous candidiasis, hypoparathyroidism, and adrenocortical insufficiency may not be present in initial stages.
Purpose of the Study:
- To highlight the variability in the clinical presentation of APS-I/APECED.
- To emphasize the importance of considering a broad spectrum of symptoms for accurate diagnosis.
- To guide diagnostic strategies beyond solely relying on characteristic manifestations.
Main Methods:
- Review of clinical data and literature on APS-I/APECED.
- Analysis of disease components and their variability.
- Evaluation of diagnostic approaches in light of clinical heterogeneity.
Main Results:
- APS-I/APECED displays a wide range of clinical manifestations, with over 30 potential associated disorders.
- Initial symptoms can be atypical, lacking the hallmark features of candidiasis, hypoparathyroidism, or adrenal insufficiency.
- Genetic testing, while available, is insufficient to rule out the disease due to variability.
Conclusions:
- Diagnostic strategies for APS-I/APECED must encompass a comprehensive understanding of its diverse clinical picture.
- Recognition of ectodermal dystrophy features is crucial for diagnosis.
- Clinical vigilance is essential, as classic components may be absent initially.